Thursday, November 5, 2009

US Health Department Ordered Peramivir from Biocryst

On Wednesday afternoon session Biocryst has cancelled the participation for the conference schedule, that has started everyone to look back on BCRX, and the wednesday afternoon session was little highly traded for BCRX.

On Thursday US Health department has announced that it has ordered 10,000 quantitiy of vaccines from BioCryst , for Peramivir, which gives $22 million revenue to the Biocryst.

Read more information at http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66&symbol=BCRX.O×tamp=20091105120200

Apart from this, BioCryst is waiting for the Japanese Government Approval to start manufacturing Peramivir partnership with Shionogi Company. Shionogio company has already got Japanese approval for the US Drug manufacturing, and it has the US Approval as well for the Peramivir from 2007.

BCRX is now trading at $11.43, and the US Government order pushed this +1.30 from Wednesday closing, still it has lot of potential to touch $13 anytime soon, and adding the Japanese government Approval News coming in next week, will push this like DNDN or HGSI trading pattern.

Read more information at
http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66&symbol=BCRX.O×tamp=20091104120100

I would suggest to keep it for long atleast for couple more months.

Updated: The 22.5 million worth order from US Government, for 10,000 courses, tells us $2000 per course for each permavir course. And the company mentioned in the interview that it is expecting to product 120,000 courses before December 2009, which is $300 million wortb of revenue if the pricing stands same. And it is going to be the huge performance revenue for BioCrystcompany.

Read more information at http://www.tickerspy.com/blog/?p=598

All the best for BCRX holders.

Note: As i always see, please do your DD, analysis and use your best judgements. This site does not recommend any stocks, and all information provided here, is just the opinion.


No comments:

Post a Comment